GADDI, ANTONIO VITTORINO
GADDI, ANTONIO VITTORINO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
ANTONIO V. GADDI
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome.
2005 Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Piccinni MN; Fogari E; Salvadeo S; Ciccarelli L; Fogari R.
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI.
2006 Bove M.; Cicero A.F.G.; Derosa G.; Borghi C.; Manca M.; Gaddi A.V.
A dietary education program involving the general population balances the effects of menopause on cardiovascular risk factors and metabolic syndrome incidence: data from the Brisghella Heart Study
2009 Cicero AFG; Dormi A; D'Addato S; Grandi E; Gaddi AV; Borghi C.
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study
2008 Cicero AF, Derosa G, Bove M, Grandi E, Uliassi E, Borghi C, Gaddi AV.
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study.
2008 Cicero AFG; Derosa G; Bove M; Grandi E; Uliassi E; Borghi C; Gaddi AV.
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy
2008 Poluzzi E; Strahinja P; Lanzoni M; Vargiu A; Silvani MC; Motola D; Gaddi A; Vaccheri A; Montanaro N.
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.
2005 Derosa G; Gaddi AV; Piccinni MN; Ciccarelli L; Salvadeo S; Peros E; Ghelfi M; Ferrari I; Cicero AF.
Application of a new processing method to post-LDL-apheresis data.
2002 Corsini F, Cicero AF, Giannuzzi A, Gaddi A.
Assessment of the health status in the Massa Lombarda cohort: a preliminary description of the program evaluating cardio-cerebro-vascular disease risk factors and quality of life in an elderly population.
2004 Nascetti S.; Linarello S., Scurti M., Grandi E., Gaddoni M., Noera G., Gaddi A.
Assocaition between hyperCKPemia and hypercholesterolemia in general population: casual phenotype or genic cluster?
2005 Lucicesare A; Cicero AFG; Bove M; Aronis K; Bernardi R; Gaddi A.
Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
2004 BORGHI C; DORMI A; VERONESI M; SANGIORGI Z; GADDI A.; BRISIGHELLA HEART STUDY WORKING PARTY.
Attività fisica e aterosclerosi: i dati di Brisghella
2004 D'Addato S.; Dormi A.; Gaddi A.
BlueC@rdio
2008 HRS SrL (Health Ricerca e Sviluppo); società di spin off dell'Ateneo di Bologna; Noera G (Presidente); Gaddi A (Responsabile scientifico); Gaddoni M; Nascetti S; Mazzini GL; Bruggi D; et al
Brisghella Heart Study (BHS): ipertensione ed obesità.
2006 D'Addato S; Dormi A; Laghi L; Bernardi R; Fiorito A; Gaddi A; Borghi C
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor
2005 Bernardi R.; D'Addato S.; Dormi A.; Brillante R.; Laghi L.; Linarello S.; Grandi E.; Gaddi A.
Causes of statin interruption by hyperlipidaemic patients: the result of survey on 218 consecutive patients.
2005 Cicero AFG; Bove M; Lucicesare A; Laghi L; Linarello S; Bernardi R; Gaddi AV.
Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related with the lipid oxidative damage: the EUROLIVE Study.
2008 Cicero AFG; Nascetti S; López-Sabater MC; Elosua R; Salonen JT; Nyyssönen K; Poulsen HE; Zunft HJF; Kiesewetter H; de la Torre K; Covas MI; Kaikkonen J; Mursu J; Koenbick C; Bäumler H; Gaddi AV for the EUROLIVE Study Group.
Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept.
2004 GADDI A.; CICERO AF; PEDRO EJ.
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients
2005 A.F.G., Cicero; G., Derosa; M., Bove; A., Lucicesare; L., Laghi; S., D'Addato; A.Gaddi.
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone.
2005 Cicero AF; Derosa G; Gaddi A.